In a patient with ischemic stroke, all assessment scores (NIHSS, mRS, MBI, ambulation) improved at 1, 3, and 6 months after Cerebrolysin given with rehabilitation.
In plain wordsIn a patient with stroke, all assessment scores improved at 1, 3, and 6 months after Cerebrolysin given with rehabilitation.
- Peptide
- Cerebrolysin
- Outcome
- Direction not reportedStroke assessment scores (NIHSS, mRS, MBI, ambulation)
- Study
n = 1
- Outcome group
- Neuroprotection · Nervous system and cognition
- Studied dose
- 30 mL · intravenous · 10 daysAs given in this study (human).
Source sentences
After Cerebrolysin® administration, the patient demonstrated improvement in all assessment scores at 1, 3, and 6 months.
2 context sentences(design, population, supporting numbers)
After the post-stroke recovery plateau, the patient received 10 days of 30 mL intravenous Cerebrolysin® to support further neuro-recovery, together with long-term rehabilitation.
We utilized clinical standard assessment tools, including National Institutes of Health Stroke Scale (NIHSS), modified Rankin scale (mRS), modified Barthel Index (MBI), and function of ambulation, to evaluate the outcome of the patient, together with the adverse events monitoring.